We previously described a three-component CRISPR approach, which employs Cas9 58 protein and chemically synthesized crRNA and tracrRNA for efficient KI of transgenes 1,2,8 . 59
and Tyr C89S injections whose genotyping results suggested the presence of the 114 same indel on both alleles (Extended Data Fig. 3) . Genotyping of F1 pups derived from a female 115 with such a homozygous indel revealed that all pups were heterozygous for the same indel, 116 indicating that the phenomenon was not due to an indel on one allele and a large deletion 117 encompassing the cut site on the other (Extended Data Fig. 3 ). Although we could not rule out 118 that these deletions were generated by MMEJ, which can result in stereotyped indels based on 119 local homology 3, 13 , the variety of observed indels suggested that the homozygosity resulted from 120 recombination between homologs that transferred the KI or indel allele from one chromosome to 121 the other. 122
More than 20 years ago, experiments in mouse ES cells found evidence of recombination 123 events between homologous chromosomes 14, 15 . While these interhomolog repair (IHR) events 124 are now well-understood in meiotic cells, their occurrence in zygotes and somatic cells is poorly 125 described. However, recently published data from experiments attempting to correct a 4bp 126 GAGT deletion in MYBPC3 in human embryos support a potential zygotic IHR mechanism 127 whereby one allele can serve as the repair template for the other after induction of a targeted 128 double-strand break (DSB) by Cas9
16 . Based on these data, we hypothesized that RAD51 129 promotes homozygous KI through a similar mechanism. To test this, we first performed PNI 130 using an injection mixture containing an equimolar ratio of two separate ssODNs containing 131 different point mutations at the same loci, allowing us to identify independent knock-in events 132 via the observation of compound heterozygosity (Fig. 3a) . In line with our previous observations 133 (Fig. 2a) , we found that co-injection of RAD51 significantly increased homozygous KI 134 efficiency (Fig. 3b) . Strikingly, compound heterozygosity was observed in 5/12 control embryos 135 with a KI event on both alleles, but was not observed in any RAD51-injected embryos (Fig. 3b) ,supporting our hypothesis that RAD51 increases homozygosity through an enhanced IHR 137 mechanism. Importantly, we did not observe significant differences in overall KI rates between 138 the two ssODNs (Extended Data Fig. 4) , ruling out the possibility that our observations were 139 due to a bias toward one donor over the other. 140
In order to more directly test the IHR mechanism, we attempted to generate homozygous 141
Chd2
R1684H embryos without the use of an exogenous donor through homozygous conversion. 142
Using in vitro fertilization (IVF) with wildtype C57Bl/6N eggs and sperm from homozygous 143
R1684H male mice, we generated heterozygous zygotes and specifically targeted Cas9 to the 144 maternal Chd2 locus. As illustrated in Figure 3c , PNI was performed on zygotes at ~8 hours post 145 fertilization (hpf) using a mixture of crRNA, tracrRNA, and Cas9 with or without RAD51. 146
Because the Chd2 R1684H allele contains mutations in both the guide sequence and its associated 147 PAM, Cas9 is only capable of cutting the wildtype maternal allele (Extended Data Fig. 5) . 148 Therefore, by omitting the donor template from the injection mixture we were able to directly 149 test both the rate of baseline CRISPR/Cas9-mediated IHR in the zygote and the ability of 150 RAD51 to enhance such a mechanism. In support of data published by Ma et al., we observed 151 IHR events in 26% of control-injected embryos (Fig. 3d,e) . Strikingly, co-injection of RAD51 152 was capable of increasing this rate to 74% (Fig. 3e) . To directly rule out the possibility of false 153 positives resulting from monoallelic deletions on the maternal allele, we developed and 154 performed a genomic qPCR assay to analyze copy number at the targeted locus (see Methods). 155
First, using genomic DNA from wildtype mice and Shank3B +/-mice harboring a heterozygous 156 deletion of exon 13 of Shank3 17 , we confirmed that our method was capable of identifying 157 heterozygous deletions (Fig. 3f) . Using the same assay design, we confirmed that 5 of 5randomly selected homozygous mutants carried 2 copies of the Chd2 locus (Fig. 3f) , validating 159 our conclusion that RAD51 enhances zygotic IHR. 160
Our data demonstrate that RAD51 enhances interhomolog repair and that this 161 enhancement can be leveraged for both donor-free homozygous conversion and de novo 162 homozygous KI. To our knowledge, our results are also the first to definitively show the 163 existence of IHR events in mammalian zygotes. Although previous work has suggested the 164 existence of these events, a recent commentary in bioRxiv highlights the need for more rigorous 165
analyses to confirm such findings and outlines 3 main points 18 . First, Egli et al. argue that 166 because IHR requires physical interaction of the maternal and paternal genomes, there must be a 167 sufficient explanation for how IHR can result from Cas9-mediated DSBs that occur while the 168 maternal and paternal genomes are segregated in separate pronuclei. Second, they suggest that 169 parthenogenesis must be ruled out as a possibility for the observed loss-of-heterozygosity. Last, 170 they suggest that additional measures be taken to rule out the possibility that the observed loss-171 of-heterozygosity is due to large NHEJ-induced indels emanating from the Cas9 cut site. Our 172 data fulfills all three requirements and further goes on to show that RAD51 is capable of 173 significantly enhancing IHR. With respect to the need for physical proximity between homologs 174 to allow IHR, previous kinetic studies have shown that Cas9 can remain bound to its cut site for 175 up to 6 hours 19 , which would be long enough to allow mitotic association of the maternal and 176 paternal alleles in mouse zygotes. Furthermore, an additional study in mouse demonstrated 177 successful correction of a disease mutation in zygotes without the use of exogenous donor 178 DNA 20 , supporting the existence of a zygotic IHR mechanism. With regard to the ruling out 179 parthenogenesis, our experimental design relied upon transfer of the paternal mutation to the 180 maternal allele, excluding the possibility of a parthenogenesis-based mechanism. Last,previously published work mouse zygotes showed that the median deletion size associated with a 182
Cas9-induced cut with a single sgRNA was ~10bp, that deletions do not surpass 600bp, and that 183 the occurrence of large deletions (>100bp) was largely sequence-dependent and far too 184 infrequent to account for the high rates of IHR observed in our experiments 10 . In accordance with 185 these findings, our copy-number analyses and F1 genotyping data rule out large deletions as the 186 source of loss-of-heterozygosity and therefore support our conclusions regarding the existence 187 and enhancement of zygotic IHR. Zygotic Injections: Female mice (4-5 weeks old, C57BL/6NJ) were superovulated by IP 227 injection of PMS (5 IU/mouse, three days prior to microinjection) and hCG (5 IU/mouse, 47 228 hours after PMS injection), and paired with males. Plugged females were sacrificed by cervical 229 dislocation at day 0.5pcd and zygotes were collected into 0.1% hyaluronidase/FHM. Zygotes 230 were washed in drops of FHM and cumulus cells were removed. Zygotes were cultured in 231 KSOM-aa medium for one hour and used for microinjection. Pronuclear injection was performed 232 using a micromanipulator (Narishige), microscope (Nikon), and injector (Eppendorf). Zygotes 233 were cultured until collection for genotyping. For experiments giving rise to F0 animals, embryos 234
were surgically implanted into pseudopregnant CD-1 females (Charles River Laboratories, Strain 235
Code 022) 24 hours post-injection, allowed to develop normally, and recovered following natural 236
birth. 237
Embryo DNA Purification: Embryos were collected at morula stage in 6µL embryo digestion 238 buffer (125µg/mL proteinase K, 100mM Tris-HCl pH 8.0, 100mM KCl, 0.02% gelatin, 0.45% 239 Tween-20, 60µg/mL yeast tRNA) and digested for 1 hour at 56°C. Proteinase K was inactivated 240 via incubation at 95°C for 10 minutes. Embryo DNA was stored at -20°C until use. 241 Tail DNA Purification: Tail snips (~0.5cm length) were collected from animals, placed in 75µL 242 alkaline lysis buffer (25mM NaOH, 0.2mM EDTA), and incubated at 95°C for 30 minutes. 243
Digestion was stopped via addition of 75µL neutralization buffer (40mM Tris-HCl pH 5.0). 244
Samples were stored at 4°C until genotyping. 245
Chd2
R1684H Genotyping: Initial PCR was performed using either 3µL embryo DNA or 2µL 246 purified tail DNA. The longer amplification of the nested PCR reaction was performed using the 247
Chd2-RH_Long_F/R primer pair listed in Supplementary Table 2 and an annealing temperatureof 65°C. Nested PCR was performed using 2µL of the initial 25µL PCR reaction, the Chd2-249 RH_F/R primer pair listed in Supplementary Table 2 , and an annealing temperature of 65°C. 250
Tyr
C89S Genotyping: Initial PCR was performed using 2µL purified tail DNA. The longer 251 amplification of the nested PCR reaction was performed using the Tyr_Long_F/R primer pair 252 listed in Supplementary Table 2 and an annealing temperature of 65°C. Nested PCR was 253 performed using 2µL of the initial 25µL PCR reaction, the Tyr_F/R primer pair listed in 254
Supplementary Table 2 , and an annealing temperature of 65°C. 255
Genomic qPCR: To determine copy number at specific genomic loci, we developed a strategy 256 utilizing multiplex nested qPCR. We first performed multiplex amplification of both the edited 257
Chd2 region and a region of the Gapdh promoter, which is located on a different chromosome, in 258 a short round of PCR (10 cycles). In the case of our Shank3B control experiment, we attempted 259 to match the input DNA concentration used for experiments utilizing DNA from cultured 260 embryos. Based on an estimation of ~6pg DNA per cell and a PCR input of ~30 cells, we used 261 180pg Shank3B +/+ or Shank3B +/-genomic DNA per initial reaction. We then used the PCR 262 products from the initial multiplex PCR as input for subsequent qPCR using Sso Advanced 263 SYBR Green Supermix (Bio-Rad). qPCR was performed on a CFX96 Touch Real-Time PCR 264
Detection System (Bio-Rad) and analyzed using CFX Maestro software (Bio-Rad). Chd2 or 265
Shank3B signal was normalized to Gapdh signal to control for input and a second diploid locus. 266
Statistical Analyses: Statistical analyses were performed using Prism 6 (Graphpad). For initial 267 experiments in which the effects of RS-1 and RAD51 were unknown, as well as mixed oligo KI 268 experiments where RAD51 could potentially increase either compound heterozygosity or 269 homozygosity, two-tailed analyses were used. All other experiments exploring RAD51's ability 270 to increase KI and homozygous KI efficiencies utilized one-tailed tests. Genomic qPCR 271 performed in Figure 3 was analyzed by unpaired t-test. The graph displays mean±SEM. 272 Representative chromatograms from Tyr +/+ (top) and Tyr C89S/C89S animals. e, Genotyping of F0 360 animals generated by three-component CRISPR with or without RAD51 showed no significant 361 effect of RAD51 on overall KI efficiency (n.s.=not significant, p=0.166, one-tailed chi-square 362 test), but a significant RAD51-dependent increase in homozygous KI rates (p=0.0081, one-tailed 363 chi-square test). 364 
